Strokes are the fifth leading cause of death, according to the American Stroke Association and they're also a leading cause of disability across the U.S. Dr. Reade De Leacy, a neurosurgery specialist, joined Cheddar News to talk about the importance of response time when treating patients that have suffered strokes. "In stroke, especially in major stroke, two million brain cells are lost for every minute of delay in treatment so time really, really critical," he said.
Verizon Media launches 'Yahoo Life,' a website dedicated to provided well-being services. CEO Guru Gowrappan talked to Cheddar about helping provide support for Verizon's employees and customers along with society at large.
Garret Reisman talks difficulty of returning to Earth from space as Nasa and SpaceX prepare for a return mission.
Transportation Workers Union Local 100 and the NYU School of Global Public Health are conducting a comprehensive study about why the pandemic hit the workers of New York City's transit system so hard early in the outbreak.
From Wall Street to Silicon Valley, these are the top stories that moved markets and had investors, business leaders, and entrepreneurs talking this week on Cheddar.
Dr. Anthony Fauci has told lawmakers that once a coronavirus vaccine is approved as safe and effective, Americans should have widespread access within a reasonable time.
New York City has over 6,000 high rise buildings and for the last 75 years most of the skyscrapers built were constructed with glass facades. This trend has continued in cities across the world like London, Moscow, and Shanghai. But over the years, the drawbacks have become more prominent. They may look like elegant symbols of modernity, but beyond that shimmer is a list of problems that has some leaders proposing bans. All that beauty comes at a price.
Volunteers rolled up their sleeves Monday to take part in the biggest test yet of an experimental COVID-19 vaccine.
From Wall Street to Silicon Valley, these are the top stories that moved markets and had investors, business leaders, and entrepreneurs talking this week on Cheddar.
Amgen Foundation is doubling down on its support for virtual education platform Khan Academy with a $3 million grant.
Sorrento Therapeutics has been approved by the FDA to move forward with Phase 2 trials of its 'Abivertinib' study. ICU patients in some SoCal hospitals will undergo testing of the orally administered drug.
